Uppsala, Sweden, February 12, 2013 – Olink Bioscience today announced the appointment of Sigma® Life Science, the innovative biological products and services business unit of Sigma-Aldrich Corporation, as distributor of the Duolink® In Situ product line in nearly all geographies worldwide for the research market. The agreement will expand the market for Duolink In Situ by leveraging the industry-leading marketing, sales, support and distribution power of Sigma® Life Science. Olink Bioscience will continue to develop the protein biomarker market.
“We believe our agreement will build awareness and develop the market for Duolink In Situ through the global sales and support organization that serves our growing customer base locally ”said Simon Fredriksson, CEO and President of Olink Bioscience. “The Sigma® Life Science product range for Cell Biology is extensive and a perfect context for customers interested in Duolink In Situ.”
“Duolink In Situ is a powerful addition to our portfolio of Proteomics products and will be readily
available through the sigma-aldrich.com website", said Josef Zihlmann, Vice President, Marketing, Sigma Life Science. "The ability to visualize protein-protein interactions in unmodified cells under endogenous expression is a fundamental advance, and can provide enhanced insight into basic biology, disease-relevant signaling pathways, and potential therapeutic compounds that can manipulate those pathways”.
About Olink AB
Olink Bioscience develops, manufactures, and markets unique and highly innovative proprietary products for biomarker research and discovery. Together with our customers and collaborators
we aim to improve clinical decision making by the use of molecular biomarkers. Our groundbreaking tools gain new insights in disease processes, improve disease detection, and contribute to a better understanding of biology. The Duolink In Situ product line enables detailed analyses of cell signaling
pathways by microscopic visualization and quantification of endogenous protein interactions and modifications. Duolink is today used by a broad customer base worldwide in both academia and pharmaceutical industry. Proseek® is a next generation multivariate protein biomarker detection product. It uniquely allows multiplexing of immunoassays without compromising assay performance. Proseek simultaneously quantifies up to 96 proteins in just 1 μl liquid samples such as serum and plasma with exceptional analytical performance.
Olink’s patented molecular technologies are also commercialized through out-licensing to industry leading partners such as Affymetrix, Life Technologies, and through the spin-out companies Qlinea and Halo Genomics (now part of Agilent). Olink Bioscience is headquartered in Uppsala, Sweden.
For more information, please contact:
Simon Fredriksson, President and CEO, Olink AB
Phone: +46 18 444 3970
Mobile: +46 76 1169442
Olink and Duolink are registered trademarks of Olink AB. Sigma-Aldrich and Sigma are trademarks of Sigma-Aldrich Co. LLC registered in the US and other countries.